Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG

Media Advisory - MP Housefather to announce investment in dementia research


MONTREAL, Jan. 22, 2018 /CNW/ - Mr. Anthony Housefather, Member of Parliament for Mount Royal, will announce, on behalf of the Honourable Ginette Petitpas Taylor, Minister of Health, funding to advance dementia research in Canada and tour the Jewish General Hospital's Lady Davis Institute.

He will be joined by Dr. Yves Joanette, Scientific Director of CIHR's Institute of Aging and Chair of the World Dementia Council, and Dr. Gerard Batist, Acting Director of the Lady Davis Institute.

 

Date:

Tuesday, January 23, 2018

Time:

9:30 a.m. ? Announcement




9:45 a.m. ? Tour

Location:

Jewish General Hospital

Pavilion A, 2nd Floor, Library Foyer


5750 Côte-des-Neiges Road

Montreal, Quebec

                                   

SOURCE Canadian Institutes of Health Research


These press releases may also interest you

at 04:31
Aquaporin raises DKK 172 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance HealthCare Group expands luxury mental health and addiction services for UHNW individuals
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions and The Pathway join forces to elevate continuing education in restorative dentistry.
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
4 university colleges in Denmark join forces to enhance on-site and remote education for radiographers with Sectra Education Portal
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

More news about Health...


News published on and distributed by: